Your browser doesn't support javascript.
loading
First-in-Human Phase I Study of GSK2126458, an Oral Pan-Class I Phosphatidylinositol-3-Kinase Inhibitor, in Patients with Advanced Solid Tumor Malignancies.
Munster, Pamela; Aggarwal, Rahul; Hong, David; Schellens, Jan H M; van der Noll, Ruud; Specht, Jennifer; Witteveen, Petronella O; Werner, Theresa L; Dees, E Claire; Bergsland, Emily; Agarwal, Neeraj; Kleha, Joseph F; Durante, Michael; Adams, Laurel; Smith, Deborah A; Lampkin, Thomas A; Morris, Shannon R; Kurzrock, Razelle.
Afiliación
  • Munster P; University of California, San Francisco, California. pmunster@medicine.ucsf.edu.
  • Aggarwal R; University of California, San Francisco, California.
  • Hong D; MD Anderson Cancer Center, Houston, Texas.
  • Schellens JH; The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van der Noll R; The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Specht J; Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Witteveen PO; Cancer Center University Utrecht, the Netherlands.
  • Werner TL; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
  • Dees EC; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.
  • Bergsland E; University of California, San Francisco, California.
  • Agarwal N; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
  • Kleha JF; GlaxoSmithKline, Research Triangle Park, North Carolina.
  • Durante M; GlaxoSmithKline, Collegeville, Pennsylvania.
  • Adams L; GlaxoSmithKline, Research Triangle Park, North Carolina.
  • Smith DA; GlaxoSmithKline, Research Triangle Park, North Carolina.
  • Lampkin TA; GlaxoSmithKline, Research Triangle Park, North Carolina.
  • Morris SR; GlaxoSmithKline, Research Triangle Park, North Carolina.
  • Kurzrock R; MD Anderson Cancer Center, Houston, Texas.
Clin Cancer Res ; 22(8): 1932-9, 2016 Apr 15.
Article en En | MEDLINE | ID: mdl-26603258

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Quinolinas / Sulfonamidas / Fosfatidilinositol 3-Quinasa Clase I / Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Quinolinas / Sulfonamidas / Fosfatidilinositol 3-Quinasa Clase I / Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article